After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, AXSM falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Axsome Therapeutics Inc is $6.77B. A total of 1.24 million shares were traded on the day, compared to an average of 526.39K shares.
In the most recent transaction, Herriot Tabuteau bought 91,705 shares of AXSM for 135.75 per share on Nov 03 ’25. In a previous transaction on Oct 06 ’25, TABUTEAU HERRIOT sold 19,220 shares at 120.17 per share. AXSM shares that Chief Executive Officer owns now total 7,229.
Among the insiders who sold shares, TABUTEAU HERRIOT disposed of 13,390 shares on Oct 07 ’25 at a per-share price of $118.77. This resulted in the Chief Executive Officer holding 7,229 shares of AXSM after the transaction. In another insider transaction, TABUTEAU HERRIOT sold 12,774 shares at $118.84 per share on Oct 08 ’25. Company shares held by the Chief Executive Officer now total 7,229.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, AXSM has a high of $139.13 and a low of $75.56.
As of this writing, AXSM has an earnings estimate of -$0.66 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$1.07. The company reported an EPS of -$1.54 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. AXSM’s latest balance sheet shows that the firm has $86.47M in Cash & Short Term Investments as of fiscal 2021. There were $49.71M in debt and $23.07M in liabilities at the time. Its Book Value Per Share was $1.47, while its Total Shareholder’s Equity was $15.63M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXSM is Buy with a score of 4.81.
